About
Codon Devices is the founder of Constructive Biology™, a transformative discipline that applies engineering principles to the design and construction of genetic sequences. The company's proprietary industrial platform enables researchers to build genetic sequences rapidly, cost-effectively, and at unprecedented lengths — overcoming the limitations of traditional gene synthesis methods. The platform serves a wide range of applications: in molecular biology and basic research, it accelerates the development of engineered constructs; in pharmaceuticals, it supports improved therapeutic protein development, engineered therapeutic production, and rapid-response vaccine creation; in industrial biology and energy, it enables the development of enzymes and cell factories; and in agriculture, it powers precision trait engineering. By drawing parallels to the recombinant DNA revolution, Codon Devices positions Constructive Biology™ as the next major leap in biotechnology — enabling scientists and engineers to systematically design, build, and iterate on biological systems at scale. The platform is intended for pharmaceutical companies, research institutions, biotech startups, and industrial biology organizations seeking to accelerate their discovery and production pipelines. Named to the Red Herring 100 and partnered with Open Biosystems, Codon Devices established itself as a leader in the synthetic genomics space, offering both research tools and commercial gene construction services.
Key Features
- Industrial Gene Construction Platform: Proprietary technology enabling the design and construction of genetic sequences at industrial scale, quickly, inexpensively, and at virtually unlimited lengths.
- Pharmaceutical Applications: Supports improved therapeutic protein development, natural and engineered therapeutic production, and rapid-response vaccine development.
- Industrial Biology & Energy Solutions: Enables development of enzymes and cell factories for industrial biology, bioenergy, and metabolic engineering use cases.
- Agricultural Precision Trait Engineering: Facilitates precision trait engineering in agriculture by enabling targeted genetic sequence construction for crop and organism improvement.
- Broad Research Support: Covers molecular biology, basic research, and structural/functional genomics, giving researchers engineered constructs at scale.
Use Cases
- Pharmaceutical companies developing engineered therapeutic proteins or biologics at scale using custom gene constructs.
- Vaccine developers requiring rapid gene sequence construction for fast-response immunization programs.
- Industrial biotech firms engineering enzymes and cell factories for bioenergy or chemical production pipelines.
- Agricultural research organizations engineering precision genetic traits in crops or model organisms.
- Academic and structural genomics labs needing large, accurate synthetic gene libraries for functional research.
Pros
- Pioneering Technology: Codon Devices introduced a fundamentally new approach to gene construction, enabling engineering-level control over biological design.
- Wide Application Range: Serves diverse sectors including pharmaceuticals, agriculture, industrial biology, and basic academic research from a single platform.
- Scalable and Cost-Effective: The industrial platform is designed to produce genetic sequences quickly and inexpensively, reducing barriers to large-scale biological research.
Cons
- Highly Specialized Use Case: The platform is designed for professional researchers and biotech organizations, making it inaccessible to general users or smaller labs without resources.
- Limited Public Pricing Transparency: Pricing and service details are not publicly listed, requiring direct engagement with the company for project scoping.
Frequently Asked Questions
Constructive Biology™ is a discipline pioneered by Codon Devices that applies engineering principles to biological research, enabling scientists to design and construct genetic sequences systematically and at scale.
Codon Devices serves the pharmaceutical, agricultural, industrial biology, energy, and basic research sectors with its gene construction platform.
Unlike traditional gene synthesis, Codon Devices' proprietary platform supports virtually unlimited sequence lengths and industrial-scale throughput at significantly lower cost and turnaround time.
Yes, Codon Devices offers rapid-response vaccine development capabilities as part of its pharmaceutical application suite.
Codon Devices signed a distribution agreement with Open Biosystems in June 2007 to expand access to its gene construction products.